Graham v Northern Bank - Farmland Sale Injunction Dispute

The High Court of Justice in Northern Ireland, Chancery Division, delivered judgment on 13 March 2026 in Graham & Anor v Northern Bank Ltd t/a Danske Bank & Ors [2026] NICh 14, dismissing the plaintiffs' application for an interim injunction to restrain the defendants (Northern Bank and its joint fixed charge receivers) from completing the sale of approximately 44.71 acres of farmland at Raleagh Road, Crossgar, County Down. The plaintiffs claimed the bank failed to obtain the best price reasonably obtainable when selling charged lands securing debt of approximately £485,000 across three facility agreements. The court found the balance of convenience did not favour continuing the injunction, with planning permission issues and the plaintiffs' Individual Voluntary Arrangement failures weighing against them.

DEQ Awards $1.5M to Lewiston for Wastewater PFAS Treatment

The Idaho Department of Environmental Quality awarded $1,501,280 in low-interest loan funding to the City of Lewiston in Nez Perce County on March 31, 2026. The funding targets PFAS, pharmaceuticals, and endocrine-disrupting chemicals through installation of water mains in the East Orchards neighborhood and conversion of homes from septic to public wastewater treatment. The loan carries 0% interest with $1,501,280 in principal forgiveness, representing $2,808,964 in savings compared to municipal general obligation debt.

FRA Incoming Response Letter

The Federal Railroad Administration issued an incoming response letter in March 2026, filed under docket FRA-2024-0124. The document is accessible via Regulations.gov as attachment_1.pdf. The specific content and subject matter of the correspondence cannot be determined from available metadata.

Railroad Safety Waiver Petition

FRA posted waiver petition FRA-2012-0068-0016 with an HRRC Petition Order signed 03-11-2026. The petition seeks regulatory relief from certain railroad safety requirements and is now available for public review. The specific scope of the waiver request is contained in the attached documents.

OCRB Decision FRA-2024-0129

The Federal Railroad Administration Office of Railroad Safety (OCRB) posted a formal decision in docket FRA-2024-0129. The decision document details the agency's resolution of a railroad safety compliance matter. Regulated parties subject to this docket should review the decision for any applicable requirements.

IS Tech Petitions FRA for Alternative Air Brake Test Standard

The Federal Railroad Administration published notice that IS Technology Solutions petitioned for special approval to use an automatic signal car testing device (ASCTD) as an alternative to manual single car testing devices for compliance with 49 CFR § 238.311. The petition also proposes annual device calibration instead of the current 92-day calibration cycle.

FRA Decision Letter

The Federal Railroad Administration issued a decision letter dated March 31, 2025, in response to a petition or application under docket FRA-2025-0590. The specific content and details of the decision are contained in the attached PDF document.

FRA Expansion Petition - Closed Docket

The Federal Railroad Administration issued a notice regarding the closure of a petition docket (FRA-2025-0071) seeking regulatory expansion. The petition, which requested expansion of existing FRA regulations, has been administratively resolved. No specific regulatory requirements, compliance deadlines, or penalties are associated with this docket closure notice.

OCR B Decision - Railroad Safety Compliance

The Federal Railroad Administration issued an OCR B Decision (FRA-2024-0130) addressing railroad safety compliance matters. The decision establishes findings and requirements for the regulated party regarding operational safety standards under federal railroad regulations.

Extension of Request Deadline for OR Granting Extension Request

The Federal Railroad Administration issued a notice extending a request deadline to March 31 for an OR Granting Extension Request filed under docket FRA-2026-0463. The document consists of a redacted PDF attachment related to the extension request.

New Competitive Negotiated Service Agreements

The Postal Regulatory Commission published a notice on April 1, 2026, announcing Postal Service filings for new competitive negotiated service agreements under dockets MC2026-176 and K2026-176. The notice invites public comments on whether the proposed agreements are consistent with Title 39 requirements, with comments due April 6, 2026. This administrative filing may add or modify products on the Competitive product list.

National Blood Collection and Utilization Survey Information Collection

The CDC published a Federal Register notice extending the public comment period for the proposed National Blood Collection and Utilization Survey (NBCUS). The survey is a biennial data collection effort designed to produce national and regional estimates of blood collections, utilization, and safety. Comments on the proposed information collection are due 30 days from the April 1, 2026 publication date.

Determination That INAPSINE Droperidol Injection Was Not Withdrawn From Sale for Safety

The FDA determined that INAPSINE (droperidol) injection, 2.5 mg/mL, was not withdrawn from sale for reasons of safety or effectiveness. This determination allows FDA to continue approving ANDAs (abbreviated new drug applications) that refer to this product, which is currently listed in the Orange Book's Discontinued Drug Product List. The drug was originally approved under NDA 016796 held by Akorn, Inc.

Priority Review Voucher Issuance for YUVIWEL Rare Pediatric Disease Product

The FDA announced the issuance of a priority review voucher to Ascendis Pharma Growth Disorders (A/S) for YUVIWEL (navepegritide), approved February 27, 2026. The drug is indicated to increase linear growth in pediatric patients 2 years of age and older with achondroplasia with open epiphyses. This notice fulfills FDA's statutory requirement to publish awards of priority review vouchers under section 529 of the FD&C Act.

Acceptable Market Name Change for Certain Rockfish Species

The FDA issued a notice requesting data and information to support an evidence-based determination on potential updates to the acceptable market name for 18 Sebastes rockfish species. This consultation invites stakeholders to submit comments and supporting data on the proposed market name change by May 1, 2026.

ONC Health IT Organization and Authority Structure Updates

HHS published a Federal Register Notice on April 1, 2026, reorganizing ONC (Office of the National Coordinator for Health Information Technology) by reversing the management title of Assistant Secretary for Technology Policy and restoring ONC as a singularly titled office. The roles of the HHS Chief Technology Officer, Chief AI Officer, and Chief Data Officer will no longer be part of ONC, and the organizational structure is consolidated into three offices.

Petition to Remove Three Solvents from Color Additive Regulations

The FDA announced receipt of a color additive petition from the International Association of Color Manufacturers (IACM) requesting removal of three solvents from 21 CFR Part 73. The petition targets methylene chloride, trichloroethylene, and ethylene dichloride, citing permanent abandonment of these uses in color additive preparation. The FDA is seeking public comments through June 1, 2026.

TÜV SÜD Product Services GmbH Voluntary NRTL Termination

OSHA published a notice announcing that TÜV SÜD Product Services GmbH voluntarily terminated its recognition as a Nationally Recognized Testing Laboratory (NRTL), effective March 5, 2026. The company notified OSHA on May 22, 2025, that it would not seek renewal of its recognition expiring March 5, 2026. Existing certifications were transferred to TÜV SÜD America, Inc.

Nasdaq GEMX GPS Antenna Service Removal Date Extension

The SEC published Nasdaq GEMX's proposed rule change to extend the deadline for terminating dedicated GPS antenna co-location services under Rule General 8, Section 1(d). The Exchange originally set the removal date as April 1, 2026, and now proposes to extend that date. The SEC is soliciting public comments on the proposed change.

Nasdaq GPS Antenna Removal Deadline Extension

The SEC published Nasdaq's proposed rule change to extend the deadline for removing dedicated GPS antennas from co-location services at the Carteret, NJ data center. The original compliance date of April 1, 2026 would be extended to allow existing customers additional time. The Exchange filed SR-NASDAQ-2026-019 on March 19, 2026, and the SEC is soliciting public comments on the proposal.

NYSE Rights Listing Expansion Amendment

The SEC issued a notice extending the review period for NYSE's proposed rule change to expand rights listing circumstances under Section 703.12(II) of the NYSE Listed Company Manual. The original 45-day review period expiring April 3, 2026 has been extended to May 18, 2026 (File No. SR-NYSE-2026-05). No comment letters were received during the initial comment period.

SEC Approves CAT NMS Plan Amendment Reducing Consolidated Audit Trail Costs

The SEC approved amendments to the CAT NMS Plan implementing cost savings measures for the Consolidated Audit Trail system. CAT LLC filed the proposed amendment on behalf of Plan Participants. The 2024 Cost Savings Amendment achieved approximately $30 million in annual savings, and this amendment builds on those efforts to further reduce CAT operating costs.

SEC deregistration application, Investment Company Act, March 2026

SEC deregistration application, Investment Company Act, March 2026

Schedule 13E-4F Paperwork Reduction Act Extension Request

The SEC filed notice with OMB seeking renewal of the previously approved collection of information for Schedule 13E-4F, used by Canadian foreign private issuers making cash tender or exchange offers when less than 40% of the securities are held by U.S. holders. The estimated annual burden is 3 hours (3.33 hours per response × 1 response). The public may comment on this information collection request within 30 days by May 4, 2026.

Nasdaq MRX GPS Antenna Service Removal Date Extension

The SEC published a notice on March 27, 2026, soliciting comments on Nasdaq MRX's proposed rule change to extend the date for terminating dedicated GPS antenna services at its co-location facility in Carteret, NJ. The original termination date of April 1, 2026, is being extended to allow existing customers additional time to transition to shared GPS antenna services or remove their equipment.

Request for Nominations for PCORI Board of Governors

The Government Accountability Office (GAO) is requesting letters of nomination and resumes for the Patient-Centered Outcomes Research Institute (PCORI) Board of Governors. Nominations are sought for a physician, a quality improvement or health services researcher, and a representative of private payers representing self-insured employers. Terms end in September 2026.

Lake Flower Dam Hydroelectric Project Scoping Notice

FERC published a notice opening a scoping period for the Lake Flower Dam Hydroelectric Project relicensing (Project No. 8369-050) in Saranac Lake, New York. The Commission requests written public comments on environmental issues to be addressed in the NEPA document. Comments must be received by April 27, 2026.

Kenai LNG Cool Down Expansion Project - Scoping Period and Public Comment Request

The Federal Energy Regulatory Commission (FERC) has opened a 30-day public scoping period to gather input on environmental issues for the Kenai LNG Cool Down Expansion Project proposed by Trans-Foreland Pipeline Company LLC in Kenai Peninsula Borough, Alaska. Comments must be submitted by April 27, 2026. This is a standard NEPA procedural step in FERC's review process to determine whether the LNG expansion project is in the public interest.

Combined Notice of Filings - Natural Gas Pipeline Rate and Refund Reports

FERC published a Combined Notice of Filings listing natural gas pipeline rate and refund report filings received between March 26-27, 2026. The notice covers seven dockets (RP26-679 through RP26-684) involving pipeline operators including Southern Natural Gas Company, Viking Gas Transmission, Bear Creek Storage, Midcontinent Express Pipeline, Rockies Express Pipeline, and Trailblazer Pipeline Company. Comment dates range from April 7-8, 2026.

Lake Flower Dam Hydroelectric License Application - Motions to Intervene

FERC has accepted for filing a subsequent license application from the Village of Saranac Lake for the Lake Flower Dam Hydroelectric Project (P-8369-050) located on the Saranac River in Franklin and Essex Counties, New York. The Commission is soliciting motions to intervene and protests from interested parties by May 26, 2026. The project includes a 134-foot-long, 33-foot-high dam with spillway, gates, and impoundment.

Bulk Manufacturer of Controlled Substances Application: Royal Emerald Pharmaceuticals

The DEA published a notice that Royal Emerald Pharmaceuticals applied to register as a bulk manufacturer of Schedule I controlled substances including Marihuana Extract (7350), Marihuana (7360), and Tetrahydrocannabinols (7370) at its facility in Desert Hot Springs, California. The company proposes to provide cannabis botanical raw material and active pharmaceutical ingredients (API) to DEA-registered researchers and manufacturers. Public comments on the application are due June 1, 2026.

Controlled Substance Importer Application - Fisher Clinical Services

The DEA published a notice that Fisher Clinical Services, Inc. has applied to be registered as an importer of controlled substances. The application covers 3,4-Methylenedioxy-methamphetamine (MDMA, Schedule I, Drug Code 7405) for clinical trials only. The public comment period closes May 1, 2026.

Bulk Manufacturer of Controlled Substances Application: Pharmaron Manufacturing Services (US) LLC

The DEA published a notice that Pharmaron Manufacturing Services (US) LLC applied on February 10, 2026 to be registered as a bulk manufacturer of Schedule II controlled substances (Oxycodone, Thebaine, Oxymorphone, and Noroxymorphone) at its facility in Coventry, Rhode Island. The company plans to produce material for clinical trials only. The public has until June 1, 2026 to submit comments or objections to the application.

Indivior Manufacturing LLC Controlled Substances Importer Application

The Drug Enforcement Administration published notice that Indivior Manufacturing LLC (Raleigh, NC) applied to be registered as an importer of Thebaine (drug code 9333, Schedule II controlled substance). The company plans to import the controlled substance for research, clinical trials, analytical purposes, and manufacturing process development. The public comment period closes May 1, 2026.

Controlled Substance Importer Application: Fisher Clinical Services

The Drug Enforcement Administration published a notice that Fisher Clinical Services, Inc. applied to be registered as an importer of a Schedule I controlled substance (3,4-Methylenedioxymethamphetamine, Drug Code 7405). The company plans to use the substance for clinical trials only. Registered manufacturers and applicants may submit comments or objections on or before May 1, 2026.

Sterling Wisconsin LLC, controlled substances importer application

The Drug Enforcement Administration published a notice that Sterling Wisconsin, LLC applied to be registered as an importer of controlled substances (Drug Code 7431 - 5-Methoxy-N,N-dimethyltryptamine, Schedule I). The company plans to import this substance as bulk Active Pharmaceutical Ingredient for internal research, clinical investigational studies, and analytical purposes. Comments on the application are due May 1, 2026.

Importer of Controlled Substances Application: Research Triangle Institute

The DEA published notice that Research Triangle Institute applied to be registered as an importer of Schedule I controlled substances, including cathinone derivatives and synthetic stimulants. The application covers basic class(es) of controlled substances listed in the Federal Register. Interested parties may submit comments or objections, or request a hearing on the application.

NYSE Proprietary Market Data Fee Amendments

NYSE filed a proposed rule change with the SEC to amend its Proprietary Market Data Fee Schedule, introducing three key modifications: establishing a new NYSE BBO Digital Media Enterprise Fee at $40,000 per month, extending that fee to NYSE BBO Enterprise Fee subscribers, and extending the NYSE Trades Digital Media Enterprise Fee to NYSE Trades Enterprise Fee subscribers. The Digital Media Enterprise use case permits market data vendors, television broadcasters, website and mobile device service providers to redistribute real-time best-bid-and-offer information to end users via television, websites, and mobile devices, with vendors prohibited from providing the data in any context enabling trading or order routing decisions. Subscribers taking combined licensing (NYSE BBO Enterprise plus NYSE BBO Digital Media) would pay a flat $40,000 per month instead of the prior combined cost of $65,000 per month, representing a consolidation of existing and new fee categories rather than a net increase for bundled subscribers.

NYSE Amer Proposes $5,000 Monthly Digital Media Enterprise Fee

NYSE American LLC filed a proposed rule change (SR-NYSEAmer-2026-24) with the SEC on March 16, 2026, to amend its Equities Proprietary Market Data Fee Schedule. The Exchange proposes to establish a NYSE American BBO Digital Media Enterprise Fee of $5,000 per month, extend the BBO Digital Media fee to existing BBO Enterprise Fee subscribers, and extend the NYSE American Trades Digital Media Enterprise Fee to Trades Enterprise Fee subscribers. A subscriber choosing combined licensing for both NYSE American BBO enterprise and BBO Digital Media use would pay a flat $5,000 per month rather than $8,000 per month for each product separately. The SEC published this notice on March 30, 2026, to solicit comments from interested persons.

Short Term Options Series Program Expansion

NYSE American LLC filed a proposed rule change on March 27, 2026, requesting approval to permit up to two Monday and Wednesday expirations for options on qualifying individual stocks or Exchange-Traded Fund Shares. Qualifying Securities must meet specific criteria including market capitalization greater than $700 billion for individual stocks, AUM exceeding $50 billion for ETFs, monthly options volume greater than 10 million sides, position limits of at least 250,000 contracts, and participation in the Penny Interval Program. The SEC is soliciting comments on this proposed rule change, which would expand the Short Term Options Series Program beyond its current Friday-only weekly expiration structure.

EAFE and EM Options Fee Schedule Amendment

NYSE American LLC filed a proposed rule change with the SEC on March 16, 2026, to amend the NYSE American Options Fee Schedule to establish transaction fees for trading options overlying the MSCI EAFE Index (MXEA) and the MSCI Emerging Markets Index (MXEF). The Exchange proposes per-contract fees ranging from $0.25 to $0.45 depending on participant type, with Broker-Dealer, Customer, and Firm all at $0.25 per contract for Penny and Non-Penny manual transactions, while e-Specialist is assessed $0.45. The proposed fees take effect on March 16, 2026, the day trading in these index options begins on the Exchange. Comments are due April 21, 2026.

Extends Non-Customer Complex Surcharge, Adds Floor Broker Rebate

NYSE American LLC filed a proposed rule change with the SEC (Release No. 34-105086, SR-NYSEAMER-2026-19) to extend its $0.12 per contract Non-Customer Complex Surcharge to Manual non-Simple orders (currently applicable to Electronic orders only) and to establish a new $0.20 per contract Floor Broker rebate for orders trading against Market Maker orders on the Trading Floor. The filing was submitted March 11, 2026, published in the Federal Register on March 31, 2026, and designated effective March 10, 2026. The Exchange states the changes are consistent with pricing practices at competing options exchanges and would continue to incentivize Floor Broker participation on the Trading Floor.

Amends Options Regulatory Fee Assessment Methodology

NYSE American LLC filed a proposed rule change (SR-NYSEAMER-2026-22) with the SEC to amend the methodology for assessing and collecting its Options Regulatory Fee (ORF). The Exchange intends to implement the new ORF methodology effective July 1, 2026, contingent upon all U.S. options exchanges filing similar methodologies by April 1, 2026. The Exchange will continue collecting ORF under its current methodology until the new methodology is implemented or operational issues are resolved.

DCIA Aging and Compliance Data Requirements for Guaranty Agencies - Comment Request

The Department of Education is requesting public comments on a reinstatement without change of a previously approved information collection (OMB Control No. 1845-0160) related to DCIA Aging and Compliance Data Requirements for Guaranty Agencies. The collection supports reporting to Treasury on the status of non-tax debt portfolio under the Debt Collection Improvement Act and DATA Act. Comments are due May 1, 2026. The estimated annual burden is 726 hours across 275 responses.

Vaping Duty Stamps: Dimensions, Security Features, Purchase Limits, and Digital Activation Requirements

HMRC has published final guidance on the UK Vaping Products Duty stamp scheme, effective 1 April 2026. Transitional stamps (physical security features only) will be available until 31 August 2026; digital stamps with scannable codes for supply-chain tracing become mandatory from 1 October 2026, with full market compliance required by 1 April 2027. Only HMRC-approved purchasing operators (UK manufacturers, warehousekeepers, and UK representatives) may purchase stamps from the appointed supplier, subject to rolling 3-month purchase limits and mandatory reconciliation and security controls.

VAT Import One Stop Shop Scheme for an Intermediary: Service Availability and Issues

HMRC published guidance on 1 April 2026 detailing service availability and known issues affecting the VAT Import One Stop Shop (IOSS) scheme for intermediary online services. The page serves as a centralised reference point for intermediaries using the IOSS to track system status and technical problems. Businesses relying on IOSS for VAT reporting on low-value imported goods should monitor this page for real-time updates on service disruptions.

Application Withdrawal for Excise Warehousekeeper

HMRC has published guidance for applicants seeking to withdraw their excise warehousekeeper application for alcohol, tobacco and vaping products before approval is granted. The withdrawal process may be completed online via the Government Gateway portal or by written correspondence to HMRC, with a stated aim to review submissions within 45 working days. This guidance clarifies that withdrawal is only possible prior to approval—once approved, applicants cannot withdraw their application.

Vaping Products Duty: £2.20 Per 10ml and Payment Procedures

HMRC has published guidance on the new Vaping Products Duty, effective 1 April 2026, setting a flat rate of £2.20 per 10ml of vaping liquid (equivalent to £0.22 per 1ml). The duty applies to all vaping liquid whether or not it contains nicotine, and is payable at the point of manufacture for domestic production or at customs declaration for imports. Businesses must register for and use HMRC's Manage your Vaping Products Duty online service, with monthly payments due by the 15th of each month. HMRC will use the greatest volume figure when packaging, invoice, or delivery note information conflicts, and has specified measurement precision requirements (nearest 0.1ml for products under 1 litre, nearest 1ml for 1 litre or more).

Vaping Products Duty and Vaping Duty Stamps Force of Law Notice

HMRC published a Force of Law Notice on 1 April 2026 confirming that notices issued under Part 4 of the Finance Act 2026, the Vaping Products (Production, Duty Stamps and Commencement) Regulations 2026, and the Vaping Duty Stamps (Requirements, Reviews and Appeals) Regulations 2026 carry the force of law. The page provides links to the attached legal text but contains no new compliance obligations, penalties, or deadlines beyond those already established in the referenced primary and secondary legislation.